Collaborative Research on the Transition From Acute to Chronic Pain New Models and Measures in Clinical and Preclinical Pain Research (R01) | Apply Online

Opportunity Summary:

This funding opportunity, titled "Collaborative Research on the Transition From Acute to Chronic Pain: New Models and Measures in Clinical and Preclinical Pain Research (R01)" (Funding Opportunity Number RFA-DE-12-003), is an NIH discretionary grant program aimed at pushing the field toward a clearer, more actionable understanding of why some people recover from acute pain while others go on to develop chronic pain disorders. The core idea is that chronic pain is not simply acute pain that lasts longer; it often reflects a shift into a dysfunctional biological and behavioral state. By supporting coordinated preclinical and clinical research, the program seeks to identify what drives that shift and how it can be prevented or reversed before long-term pain becomes entrenched.

The scientific focus is on the transition period from acute pain to chronic pain, with an emphasis on the biological and behavioral determinants that predict or cause this change. The opportunity highlights the practical importance of this knowledge: if researchers can determine the mechanisms and risk factors that distinguish individuals who resolve pain normally from those who transition into chronic pain, it becomes possible to design earlier and more effective interventions. In other words, the FOA is geared toward prevention and early treatment strategies that stop acute pain from becoming a chronic condition, rather than only treating chronic pain after it is established.

A major priority in the announcement is collaboration and multidisciplinary team science. NIH is explicitly looking for research teams that combine expertise in basic (preclinical) pain science and clinical pain research, and it strongly encourages bringing in perspectives and methods from outside traditional pain research. That could include fields like neuroscience, immunology, genetics, psychology, psychiatry, computational biology, bioengineering, epidemiology, or data science, depending on the proposed approach. The intention is to create novel, cross-cutting strategies that are more likely to answer difficult questions about pain chronification than single-discipline projects.

The FOA lays out three main objectives. First, it aims to assemble collaborative teams capable of applying innovative approaches to the acute-to-chronic transition problem. Second, it seeks discovery of the biological and behavioral mechanisms that actively drive the transition from an acute pain state to a chronic dysfunctional pain condition. This includes identifying mechanistic pathways as well as characterizing risk factors, which may involve factors at multiple levels such as peripheral and central nervous system changes, immune and inflammatory processes, stress-related biology, learning and memory mechanisms, affective and cognitive contributors, and behavioral patterns that may reinforce or sustain pain. Third, the FOA emphasizes the development of new models and measures, both clinical and preclinical, that are needed to detect, track, and interpret these mechanisms. This reflects a recognition that progress in this area is often limited by the tools available to model pain transitions in animals and to measure relevant processes in humans in ways that translate across settings.

A notable feature of this opportunity is that it welcomes studies that carry substantial risk as long as they have strong potential for major advances. That signal matters because it suggests NIH is looking for bold ideas, new experimental paradigms, and potentially unconventional measurement strategies that might fail but could also reshape how the field understands and studies pain chronification. The overall structure is an R01 research project grant, indicating support for substantial, hypothesis-driven (or robustly justified) research programs rather than small pilot efforts.

From an administrative and eligibility standpoint, the program falls under the health funding activity category and is associated with CFDA 93.121 (Oral Diseases and Disorders Research), with the sponsoring agency listed as the National Institutes of Health. There is no cost sharing or matching requirement. The estimated total funding level listed is $3,000,000. Eligibility is broad and includes many types of applicants: public and private institutions of higher education, nonprofits with or without 501(c)(3) status, state, county, city, and special district governments, tribal governments and tribal organizations, public housing authorities/Indian housing authorities, independent school districts, small businesses, and for-profit organizations other than small businesses. The announcement also specifies additional eligible applicant categories such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and eligible federal agencies. Importantly, non-U.S. entities (foreign institutions) are eligible to apply, and foreign components of U.S. organizations are allowed as defined by NIH policy.

Key dates included in the source information indicate the FOA was posted June 28, 2011, with an original closing date of October 27, 2011, and a current closing date of October 28, 2011, and an archive date of November 28, 2011. The full announcement is referenced via an NIH grants guide link (http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-12-003.html). For technical access issues, the contact provided is the NIH Office of Extramural Research (OER) webmaster (FBOWebmaster@OD.NIH.GOV).

Overall, the opportunity is designed for teams that can connect mechanistic biology with human-relevant pain trajectories, while also creating better experimental models and measurement tools to bridge preclinical and clinical research. The program is ultimately driven by a translational goal: identifying who is at risk for chronic pain and why, then using that knowledge to intervene early enough to prevent long-term suffering and disability.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Common Tern Habitat Restoration

Previous opportunity: Eastern Idaho Visitor Center Operations

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DE 12 003

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DE 12 003) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DE 12 003", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.